ALKS vs KMI · P/E 14, rev $1.56B vs P/E 24, $62.53B cap
Alkermes Plc (ALKS) versus Kinder Morgan Inc (KMI) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
KMI does not have a complete income-statement cache yet.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
Not investment advice. Open the ALKS and KMI stock pages for the full models.
Not investment advice.